Quick Order    Shopping Cart    Online Seminar    Contact    My Account
Home  >  About  >  Press Release

Promega & SABiosciences Agreement Enables the Most Sensitive Tools for Pathway Analysis

Madison, WI USA. (July 2009) - Promega and SABiosciences will combine their offerings to provide the most sensitive tools for interrogating specific cellular pathways via transcription factor reporters. Under the new agreement Promega recombinant firefly luciferase luc2 gene and a humanized Renilla luciferase (HRluc) gene- the 'dual luciferases'- will serve as one key reporter system for SABioscience pathway reporter assays under the Cignal™ moniker.

Cignal transcription reporters from SABiosciences offer the widest selection of pathway activity assays in the world, featuring more than 40 pathway reporters available in both DNA construct and viral particle formats. "We are pleased to include Promega's recombinant firefly and humanized Renilla luciferases as reporters in our product lines. They provide the necessary levels of sensitivity for studying the effects of drugs or genetic perturbations on many interesting and biologically relevant cell types." said Dave Martz, VP of Sales and Marketing at SABiosciences.

The Cignal products with Promega luciferase technology are currently available in tube and plate formats for multiple pathways of biological interest.

About Promega

Promega Corporation is a leader in providing innovative solutions and technical support to the life sciences industry. The company's 2,000 products enable scientists worldwide to advance their knowledge in genomics, proteomics, cellular analysis, molecular diagnostics and human identification. Founded in 1978, the company is headquartered in Madison, WI, USA with branches in 14 countries and over 50 global distributors. For more information about Promega, visit www.promega.com

About SABiosciences Corporation

SABiosciences Corporation, a privately held biotechnology company founded in 1998, envisions a new and systematic approach to biological research in the post-genomic era. In recognition of its strong performance, SABiosciences has received many awards including Fortune 5000 Fastest Growing Companies (2007 and 2008), The Scientist Magazine's 2009 Top 30 Best Places to Work Award. For more information about SABiosciences, visit www.SABiosciences.com

Contact: Penny Patterson
Director, Corporate Affairs
Promega Corporation
Phone: (608) 274-4330
E-mail: penny.patterson@promega.com

Contact: Jeffrey Hung, Ph.D.
Director of Marketing
SABiosciences Corporation
Phone : (301) 673-5124
E-mail: jhung@SABiosciences.com